Disease Prevention, Therapeutics and Diagnostics
Focus of our research
This is a cross-cutting theme aimed at novel scientific and clinical approaches to support the development of modern-day therapeutics discovery and development, and disease prevention.
We have expertise in areas including; target selection and validation, lead molecule identification and optimisation, computational drug design and disease modelling. This incorporates the work being done by Professor Mark Wheatley, who has an international reputation for his research into the structure and function of G-protein-coupled receptors (GPCRs).
Our interests include SARS-CoV-2, the immune response, metabolic disease, cardiovascular disease, cardioprotective strategies and drug safety.
We develop, test and implement clinical diagnostic, therapeutic and complex behaviour change interventions to improve health and healthcare in the community and NHS settings.
If you wish to find out more about this theme, please get in contact with Professor Chris Reynolds.
Improving society by innovative collaborative health-related research.
To carry out high quality basic and applied research that underpins disease prevention and new therapies.
|Professor Christopher Reynolds||Theme Leadfirstname.lastname@example.org|
|Professor Richard Aspinall||Associate Deanemail@example.com|
|Dr Elizabeth Bailey||Research Fellow Midwifefirstname.lastname@example.org|
|Eliot Barson||ASPiRE Fellowemail@example.com|
|Dr Bernie Burke||Associate Professorfirstname.lastname@example.org|
|Professor Jane Coad||Emeritus Professoremail@example.com|
|Dr Giuseppe Deganutti||Research Fellowfirstname.lastname@example.org|
|Dr Honglin Dong||Research Associateemail@example.com|
|Professor Helen Maddock||Executive Directorfirstname.lastname@example.org|
|Dr Hardip Sandhu||Assistant Professoremail@example.com|
|Dr Mark Turner||Research Fellowfirstname.lastname@example.org|